Data summarizing the efficacy of the new coronavirus vaccine for each mutant strain is now available
The Institute for Health Metrics and Evaluation (IHME) at the University of Washington has released data on the efficacy of the new coronavirus infection (COVID-19) vaccine. Looking at this data, it is possible to check 'which vaccine is effective against which mutant strain and how much'.
COVID-19 vaccine efficacy summary | Institute for Health Metrics and Evaluation
http://www.healthdata.org/covid/covid-19-vaccine-efficacy-summary
According to IHME, it has been found that the vaccines have the same effect on D614G and B.1.1.7 among the four major variants of COVID-19. In addition, B.1.351 and P.1 are similar in mutation mode, so the effect of the vaccine is expected to be similar.
Therefore, IHME divided the efficacy of vaccines against 'D614G and B.1.1.7' and 'B.1.351 and P.1' into 'symptom-preventing effect' and 'infection-preventing effect', and the major COVID- The effects of 19 vaccines are summarized. The table is below. The colored columns in the table mean that the estimated values have been entered because there is no specific data.
| vaccine | D614G and B.1.1.7 | B.1.351 and P.1 | ||
| Preventive effect of symptoms | Infection prevention effect | Preventive effect of symptoms | Infection prevention effect | |
| Pfizer and BioNTech | 91% | 86% | 69% | 45% |
| Moderna | 94% | 85% | 72% | 47% |
| AstraZeneca | 75% | 52% | Ten% | 6% |
| Johnson & Johnson | 72% | 72% | 64% | 42% |
| Sputnik-V | 92% | 80% | 70% | 45% |
| Novavax | 89% | 77% | 49% | 32% |
| CoronaVac | 50% | 43% | 38% | twenty five% |
| Sinopharm | 73% | 63% | 56% | 36% |
| Tianjin CanSino | 66% | 57% | 50% | 32% |
| Other mRNA vaccines | 95% | 83% | 72% | 47% |
| All vaccines | 75% | 65% | 57% | 37% |
Related Posts:
in Science, Posted by log1l_ks